Phase I Study of SPH1188-11 in NSCLC (Q63012374)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I Study of SPH1188-11 in NSCLC |
clinical trial |
Statements
SPH1188-11 (English)
0 references
Phase I, Open-label Study to Evaluate the Safety, Tolerance, Pharmacokinetics and Preliminary Efficacy of SPH1188-11 Tablets for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC). (English)
0 references
21 July 2017
0 references
April 2019
0 references
36
0 references
18 year
0 references
70 year
0 references